Product Code Database
Example Keywords: playstation -the $72-163
   » » Wiki: Diazoxide
Tag Wiki 'Diazoxide'.
Tag

Diazoxide, sold under the brand name Proglycem among others, is a used to treat low blood sugar due to a number of specific causes. This includes islet cell tumors that cannot be removed and leucine sensitivity. It can also be used in refractory cases of toxicity. It is taken .

Diazoxide, used as the salt diazoxide choline, and sold under the brand name Vykat XR, is used for the treatment of in people with Prader–Willi syndrome. It was approved for this use in the United States in March 2025.

Common side effects include high blood sugar, fluid retention, low blood platelets, a fast heart rate, increased hair growth, and nausea. Other severe side effects include pulmonary hypertension and . It is chemically similar to thiazide diuretics. It works by decreasing insulin release from the pancreas and increasing glucose release by the liver.

Diazoxide was approved for medical use in the United States in 1973. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication.

(2026). 9780857113382, Pharmaceutical Press.


Medical uses
Diazoxide is used as a in the treatment of acute or malignant hypertension.

Diazoxide also inhibits the secretion of by opening ATP-sensitive potassium channel of of the ; thus, it is used to counter hypoglycemia in disease states such as (a tumor producing insulin) or congenital hyperinsulinism.

Diazoxide acts as a positive modulator of the and , suggesting potential application as a cognitive enhancer.


Side effects
Diazoxide interferes with insulin release through its action on potassium channels. Diazoxide is one of the most potent openers of the K+ ATP channels present on the insulin producing beta cells of the pancreas. Opening these channels leads to hyperpolarization of cell membrane, a decrease in calcium influx, and a subsequently reduced release of insulin.

The US Food and Drug Administration (FDA) published a safety announcement in July 2015 highlighting the potential for development of pulmonary hypertension in newborns and infants treated with this drug.

Diazoxide has been associated with development of and stimulation of .


Research
Diazoxide, formulated as its salt diazoxide choline, is an experimental antiobesity drug being tested in people with Prader-Willi syndrome and monogenic obesity caused by mutations in the SH2B1, PCSK1, or SIM1 genes.

Page 1 of 1
1
Page 1 of 1
1

Account

Social:
Pages:  ..   .. 
Items:  .. 

Navigation

General: Atom Feed Atom Feed  .. 
Help:  ..   .. 
Category:  ..   .. 
Media:  ..   .. 
Posts:  ..   ..   .. 

Statistics

Page:  .. 
Summary:  .. 
1 Tags
10/10 Page Rank
5 Page Refs